For the Inventor, By the Inventor

Enter assignee name

Biophytis

USPTO Granted Patents = 8

EPO Patents = 14

Forward Citations = 3

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

René Lafont (8 out of 10 patents)

Stanislas Veillet (8 out of 10 patents)

Pierre Dilda (4 out of 4 patents)

4. Mathilde Latil (4 out of 6 patents)

5. Jose-Alain Sahel (3 out of 44 patents)

6. Waly Dioh (3 out of 4 patents)

7. Sophie N Raynal (2 out of 6 patents)

8. Jean-Denis Durand (2 out of 6 patents)

9. Franck F Lepifre (2 out of 12 patents)

10. Serge Camelo (2 out of 2 patents)

11. Valerie Fontaine (1 out of 2 patents)

12. Pierre-Paul Elena (1 out of 3 patents)

13. Valérie Fontaine (1 out of 2 patents)

14. Maria Serova (1 out of 1 patent)

15. Onnik Agbulut (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12551495 - Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection (2026-02-17),

2. 12440500 - Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases (2025-10-14),

3. 12215067 - Chemical compounds targeting the eye and use thereof in the treatment of eye diseases (2025-02-04),

4. 11542295 - Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies (2023-01-03),

5. 10513503 - Use of 3-deoxyanthocyanidins for treating occular diseases (2019-12-24),

6. 10316056 - Chemical compounds and use thereof for improving muscular quality (2019-06-11),

7. 10314804 - Composition containing norbixin for protecting cells of the retinal pigment epithelium (2019-06-11),

8. 9938315 - Chemical compounds and use thereof for improving muscular quality (2018-04-10),

Biophytis is a clinical-stage biotechnology company developing drug candidates for age-related diseases. The company's focus is on developing therapeutics to slow down or alter the course of chronic diseases, such as sarcopenia and age-related macular degeneration. Biophytis' lead drug candidate is Sarconeos, which is currently in clinical trials for sarcopenia, a condition characterized by loss of muscle mass and strength.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#416 in Paris

#2,022 in France

Biophytis

Forward Citations = 3

23 inventors:

René Lafont (8 out of 10 patents)

Stanislas Veillet (8 out of 10 patents)

Pierre Dilda (4 out of 4 patents)

4. Mathilde Latil (4 out of 6 patents)

5. Jose-Alain Sahel (3 out of 44 patents)

Please report any incorrect information to [email protected]

Loading…